title: Increased thymidine kinase activity in human thyroid toxic adenomas: effects of exposure to epidermal growth factor in vitro.
abstract: The activity of thymidine kinase (TK-EC 2.7.1.21)--an enzyme functioning as a part of the pyrimidine salvage pathway of DNA synthesis--is closely related to growth processes. The aim of the study was to measure TK activity in homogenates of human thyroid tissue of the following types: non-toxic nodular goiter (NTNG)--macroscopically unchanged tissue, non-toxic adenoma (NTA), and toxic adenoma (TA) (obtained from patients, who--before the surgery--had been treated with thyrostatic drugs for thyrotoxicosis). Thyroid tissue was obtained from female patients subjected to subtotal thyroidectomy at the Department of Endocrine Surgery, Medical University of Lódź. Thyroid homogenates were incubated in the presence of epidermal growth factor (EGF), used in five different concentrations (0.1 ng/ml, 1 ng/ml, 10 ng/ml, 100 ng/ml, 1000 ng/ml). TK activity was estimated by chromatographic measurements of the amount of the main reaction product--deoxythymidine monophosphate.
  
  
  RESULTS
  1) We did not observe any significant difference between TK activity in the homogenates of the thyroid tissue collected from NTNG and NTA; TK activity was clearly higher in the homogenates of adenomatous tissue, collected from the patients with TA; 2) EGF increased TK activity in the homogenates of the macroscopically unchanged tissue, collected--during surgery--from the patients with NTNG, as well as in homogenates of thyroid tissue from NTA; 3) In case of hyperactive thyroid tissue, obtained from TA, EGF tended to increase TK activity, however, without any statistical differences. Our results confirm TK increased activity in hyperactive thyroid tissue. At the same time, the obtained data suggest a certain role of EGF in goiter formation in humans.
authors.affiliation: Department of Endocrinology and Isotope Therapy, Medical University of Lódź, Polish Mother's Memorial Hospital-Research Institute, Lódź, Poland. alewin@csk.am.lodz.pl
authors.forename: Andrzej
authors.initials: A
authors.lastname: Lewiński
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Karbownik
authors.forename: Adam
authors.initials: A
authors.lastname: Gesing
authors.forename: Jan
authors.initials: J
authors.lastname: Brzeziński
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Zieliński
authors.forename: Wojciech
authors.initials: W
authors.lastname: Rode
mesh_terms: D018249:Adenoma, Oxyphilic / Q000201:enzymology*; D000818:Animals; D004789:Enzyme Activation / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000494:pharmacology; D005260:Female; D006044:Goiter, Nodular / Q000201:enzymology; D006801:Humans; D013937:Thymidine Kinase / Q000378:metabolism*; D013964:Thyroid Neoplasms / Q000201:enzymology*
chemical_list: D004815:Epidermal Growth Factor; D013937:Thymidine Kinase